Pineapple Express Cannabis (PNXP) Gains from Investment Securities (2019)
Pineapple Express Cannabis' (PNXP) quarterly Gains from Investment Securities came in at $456.0 in Q4 2019, up 200.0% quarter-over-quarter from -$456.0 in Q3 2019.
Pineapple Express Cannabis (PNXP) Gains from Investment Securities (2019) Analysis & Trends
Pineapple Express Cannabis has disclosed Gains from Investment Securities across 1 years of filings, most recently posting $456.0 for Q4 2019.
- Gains from Investment Securities for Q4 2019 came in at $456.0, changed N/A year-over-year; the trailing twelve-month figure through Jul 2020 was $456.0 (up 200.0% YoY), and the FY2023 annual result was -$10124.0, changed N/A from the prior year.
- Gains from Investment Securities came in at $456.0 for Q4 2019 at Pineapple Express Cannabis, up from -$456.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $456.0 in Q4 2019 to a low of -$456.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Pineapple Express Cannabis | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2019 | 456.00 |
| Oct 31, 2019 | 456.00 |
| Jul 31, 2019 | -456.00 |
| Jul 31, 2019 | -456.00 |